enVVeno Medical (NVNO) Return on Sales (2017 - 2019)

enVVeno Medical's Return on Sales history runs 3 years deep, the most recent figure standing at 2.57% for Q4 2019.

• On a quarterly basis, Return on Sales fell 198.0% year-over-year to 2.57% in Q4 2019; TTM through Dec 2019 was 2.57%, a 212.0% decrease from a year earlier, with the FY2019 full-year figure at 5.1%, down 434.0% from the prior year.
• Return on Sales fell to 2.57% in Q4 2019 per NVNO's latest filing, from 1.25% in the prior quarter.
• Across five years, Return on Sales topped out at 0.11% in Q4 2017 and bottomed at 2.57% in Q4 2019.
• The 3-year median for Return on Sales is 0.57% (2018), against an average of 0.73%.
• Across the five-year window, Return on Sales surged 32 bps in 2018 and plunged 198 bps in 2019, its largest moves.
• Year by year, Return on Sales stood at 0.11% in 2017, then plunged by 420 bps to 0.58% in 2018, then tumbled by 340 bps to 2.57% in 2019.
• Per Business Quant, the three latest NVNO Return on Sales figures stand at 2.57% (Q4 2019), 1.25% (Q3 2019), and 0.68% (Q2 2019).